Double blind randomized study to assess the efficacy of BF2.649 compared to placebo in add-on to sodium oxybate in the treatment of narcoleptic patients with residual excessive daytime sleepiness (EDS) during 8 weeks.

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest